Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is an aggressive cancer with a high rate of death globally. The use of bioinformatics may help to identify immune cell-related genes both as targets for potential immunotherapies and for their value associated with predicting therapy responses. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Chen, Gu, Xinyu, Li, Lanjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422634/
https://www.ncbi.nlm.nih.gov/pubmed/34488768
http://dx.doi.org/10.1186/s12935-021-02183-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422634/
https://www.ncbi.nlm.nih.gov/pubmed/34488768
http://dx.doi.org/10.1186/s12935-021-02183-5

Ejemplares similares